Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Psoriasis 1Prostatic Neoplasms 1Precancerous Conditions 1Osteoarthritis 1Neoplasm, Residual 1Multiple Sclerosis 1Healthy Subject 1Cardiovascular Diseases 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Neoplasms 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Aggressive Periodontitis 1

Interventions

Rituximab 4blinatumomab 3Whole-Body Irradiation 3Cyclophosphamide 3fludarabine phosphate 2Mycophenolic Acid 2Melphalan 2Lenalidomide 2Clofarabine 2treosulfan 1thymoglobulin 1sabatolimab 1pembrolizumab 1peginterferon alfa-2a 1obinutuzumab 1midostaurin 1ixazomib 1fludarabine 1eribulin 1daratumumab 1acalabrutinib 1Trastuzumab 1Tacrolimus 1Sodium Chloride 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Pentostatin 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Methotrexate 1Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasm, Residual × Fish Oils × Clear all
NCT03093207 2020-11-17

Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis

Universidade Estadual Paulista Júlio de Mesquita Filho

Phase 2/3 Completed
34 enrolled 8 charts

Aggressive Periodontitis, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡